This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Jul 9;305(5681):177-80; author reply 177-80.

doi: 10.1126/science.305.5681.177b.

Support for the RV144 HIV vaccine trial

Robert Belshe, Genoveffa Franchini, Marc P Girard, Frances Gotch, Pontiano Kaleebu, Marta L Marthas, Michael B McChesney, Rose McCullough, Fred Mhalu, Dominique Salmon-Ceron, Rafick-Pierre Sekaly, Koen van Rompay, Bernard Verrier, Britta Wahren, Mercedes Weissenbacher

PMID: 15247455
DOI: 10.1126/science.305.5681.177b

Comment

Support for the RV144 HIV vaccine trial

Robert Belshe et al. Science. 2004.

. 2004 Jul 9;305(5681):177-80; author reply 177-80.

doi: 10.1126/science.305.5681.177b.

Authors

Robert Belshe, Genoveffa Franchini, Marc P Girard, Frances Gotch, Pontiano Kaleebu, Marta L Marthas, Michael B McChesney, Rose McCullough, Fred Mhalu, Dominique Salmon-Ceron, Rafick-Pierre Sekaly, Koen van Rompay, Bernard Verrier, Britta Wahren, Mercedes Weissenbacher

PMID: 15247455
DOI: 10.1126/science.305.5681.177b

No abstract available

PubMed Disclaimer

Comment on

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA. Burton DR, et al. Science. 2004 Jan 16;303(5656):316. doi: 10.1126/science.1094620. Science. 2004. PMID: 14726576 No abstract available.
Policy rebuttal. HIV vaccine trial justified.
McNeil JG, Johnston MI, Birx DL, Tramont EC. McNeil JG, et al. Science. 2004 Feb 13;303(5660):961. doi: 10.1126/science.1096161. Science. 2004. PMID: 14963313 No abstract available.

Similar articles

Policy rebuttal. HIV vaccine trial justified.
McNeil JG, Johnston MI, Birx DL, Tramont EC. McNeil JG, et al. Science. 2004 Feb 13;303(5660):961. doi: 10.1126/science.1096161. Science. 2004. PMID: 14963313 No abstract available.
Support for the RV144 HIV vaccine trial.
AIDS Vaccine Advocacy Coalition. AIDS Vaccine Advocacy Coalition. Science. 2004 Jul 9;305(5681):177-80; author reply 177-80. Science. 2004. PMID: 15250069 No abstract available.
Outstanding questions on HIV vaccine trial.
Jefferys R, Harrington M. Jefferys R, et al. Science. 2004 Jul 9;305(5681):180; author reply 180. doi: 10.1126/science.305.5681.180a. Science. 2004. PMID: 15247456 No abstract available.
Therapeutic vaccine trails in Thailand.
Churdboonchart V. Churdboonchart V. J HIV Ther. 2004 Sep;9(3):57-9. J HIV Ther. 2004. PMID: 15534562 Review.
Development of prophylactic AIDS vaccines: the current state of affairs.
Hanke T. Hanke T. Curr Opin Mol Ther. 2003 Feb;5(1):25-32. Curr Opin Mol Ther. 2003. PMID: 12669467 Review.

See all similar articles

Cited by

Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.
Vaccari M, Poonam P, Franchini G. Vaccari M, et al. Expert Rev Vaccines. 2010 Sep;9(9):997-1005. doi: 10.1586/erv.10.104. Expert Rev Vaccines. 2010. PMID: 20822342 Free PMC article. Review.
"Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown.
Newman PA, Logie C, James L, Charles T, Maxwell J, Salam K, Woodford M. Newman PA, et al. Am J Public Health. 2011 Sep;101(9):1749-58. doi: 10.2105/AJPH.2011.300208. Epub 2011 Jul 21. Am J Public Health. 2011. PMID: 21778490 Free PMC article.
Vaccine Design Informed by Virus-Induced Immunity.
Penkert RR, Hankins JS, Young NS, Hurwitz JL. Penkert RR, et al. Viral Immunol. 2020 May;33(4):342-350. doi: 10.1089/vim.2019.0138. Epub 2020 May 5. Viral Immunol. 2020. PMID: 32366204 Free PMC article. Review.
Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.
Tarrés-Freixas F, Clotet B, Carrillo J, Blanco J. Tarrés-Freixas F, et al. Vaccines (Basel). 2024 Mar 12;12(3):298. doi: 10.3390/vaccines12030298. Vaccines (Basel). 2024. PMID: 38543932 Free PMC article. Review.
Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach.
Mishra SK, Senathilake KS, Kumar N, Patel CN, Uddin MB, Alqahtani T, Alqahtani A, Alharbi HM, Georrge JJ. Mishra SK, et al. PLoS One. 2025 Feb 27;20(2):e0318523. doi: 10.1371/journal.pone.0318523. eCollection 2025. PLoS One. 2025. Retraction in: PLoS One. 2025 May 6;20(5):e0324076. doi: 10.1371/journal.pone.0324076. PMID: 40014623 Free PMC article. Retracted.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information